Repeated oral trazodone in male and female rats: Sex-dependent anxiolytic-like effects, altered male sexual motivation and dose-related testicular and epididymal changes in the same animals.
Thais de Oliveira Navarro, Lilian Marques de Sá, Milena Rodrigues Soares, Leonardo Calisse, Maria Martha Bernardi, André Rinaldi Fukushima, Helenice de Souza Spinosa
{"title":"Repeated oral trazodone in male and female rats: Sex-dependent anxiolytic-like effects, altered male sexual motivation and dose-related testicular and epididymal changes in the same animals.","authors":"Thais de Oliveira Navarro, Lilian Marques de Sá, Milena Rodrigues Soares, Leonardo Calisse, Maria Martha Bernardi, André Rinaldi Fukushima, Helenice de Souza Spinosa","doi":"10.1016/j.pbb.2026.174292","DOIUrl":null,"url":null,"abstract":"<p><p>Trazodone is a multimodal antidepressant and hypnotic used off-label for insomnia and anxiety in humans and, in veterinary medicine, as an anxiolytic and sedative in dogs and cats. In both settings it is given repeatedly, largely to individuals who are not depressed, and with little regard to sex. Its behavioural and reproductive consequences have been examined separately, in separate animals; here both were assessed in the same cohort. Male and female Wistar rats received trazodone hydrochloride at 5, 10 or 20 mg/kg/day (T5, T10, T20) or vehicle by gavage for 28 consecutive days (postnatal days 60-87; n = 6-8/group), with behavioural testing from postnatal day 88, approximately 24 h after the final dose. Open-field locomotion was unaltered in either sex; female rearing was reduced only at 20 mg/kg. In the elevated plus-maze, trazodone increased open-arm time and reduced closed-arm time in males (T5, T10) and in females (T10, T20), the effective dose range being lower in males. In an incentive-zone test, T20 males spent more time in the male-incentive zone while time near the female, approaches and latency were unchanged - a loss of directional preference rather than increased sexual interest. In the same males, blinded histomorphometry showed reduced seminiferous epithelium thickness at every dose and reduced caput epididymal luminal area and perimeter; testicular and epididymal severity scores were increased at 10 and 20 mg/kg, while gonadosomatic index, relative liver weight and hepatic scores were unchanged. The dose that altered male sexual incentive behaviour was also the dose with the most pronounced testicular change. The mechanism was not tested here and remains to be established.</p>","PeriodicalId":19893,"journal":{"name":"Pharmacology Biochemistry and Behavior","volume":" ","pages":"174292"},"PeriodicalIF":2.4000,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacology Biochemistry and Behavior","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1016/j.pbb.2026.174292","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BEHAVIORAL SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Trazodone is a multimodal antidepressant and hypnotic used off-label for insomnia and anxiety in humans and, in veterinary medicine, as an anxiolytic and sedative in dogs and cats. In both settings it is given repeatedly, largely to individuals who are not depressed, and with little regard to sex. Its behavioural and reproductive consequences have been examined separately, in separate animals; here both were assessed in the same cohort. Male and female Wistar rats received trazodone hydrochloride at 5, 10 or 20 mg/kg/day (T5, T10, T20) or vehicle by gavage for 28 consecutive days (postnatal days 60-87; n = 6-8/group), with behavioural testing from postnatal day 88, approximately 24 h after the final dose. Open-field locomotion was unaltered in either sex; female rearing was reduced only at 20 mg/kg. In the elevated plus-maze, trazodone increased open-arm time and reduced closed-arm time in males (T5, T10) and in females (T10, T20), the effective dose range being lower in males. In an incentive-zone test, T20 males spent more time in the male-incentive zone while time near the female, approaches and latency were unchanged - a loss of directional preference rather than increased sexual interest. In the same males, blinded histomorphometry showed reduced seminiferous epithelium thickness at every dose and reduced caput epididymal luminal area and perimeter; testicular and epididymal severity scores were increased at 10 and 20 mg/kg, while gonadosomatic index, relative liver weight and hepatic scores were unchanged. The dose that altered male sexual incentive behaviour was also the dose with the most pronounced testicular change. The mechanism was not tested here and remains to be established.
期刊介绍:
Pharmacology Biochemistry & Behavior publishes original reports in the areas of pharmacology and biochemistry in which the primary emphasis and theoretical context are behavioral. Contributions may involve clinical, preclinical, or basic research. Purely biochemical or toxicology studies will not be published. Papers describing the behavioral effects of novel drugs in models of psychiatric, neurological and cognitive disorders, and central pain must include a positive control unless the paper is on a disease where such a drug is not available yet. Papers focusing on physiological processes (e.g., peripheral pain mechanisms, body temperature regulation, seizure activity) are not accepted as we would like to retain the focus of Pharmacology Biochemistry & Behavior on behavior and its interaction with the biochemistry and neurochemistry of the central nervous system. Papers describing the effects of plant materials are generally not considered, unless the active ingredients are studied, the extraction method is well described, the doses tested are known, and clear and definite experimental evidence on the mechanism of action of the active ingredients is provided.